BNP Paribas Financial Markets’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.23K Sell
8,703
-80,411
-90% -$76K ﹤0.01% 4073
2025
Q1
$41.1K Buy
89,114
+69,410
+352% +$32K ﹤0.01% 3515
2024
Q4
$14.6K Sell
19,704
-12,149
-38% -$8.97K ﹤0.01% 3929
2024
Q3
$50K Buy
31,853
+13,246
+71% +$20.8K ﹤0.01% 2886
2024
Q2
$31.3K Sell
18,607
-40,771
-69% -$68.5K ﹤0.01% 2895
2024
Q1
$143K Buy
59,378
+26,859
+83% +$64.5K ﹤0.01% 2679
2023
Q4
$49.8K Sell
32,519
-88,053
-73% -$135K ﹤0.01% 2851
2023
Q3
$131K Buy
120,572
+95,432
+380% +$104K ﹤0.01% 2578
2023
Q2
$57.6K Buy
25,140
+6,588
+36% +$15.1K ﹤0.01% 2805
2023
Q1
$45.1K Buy
18,552
+10,312
+125% +$25.1K ﹤0.01% 2810
2022
Q4
$15.7K Sell
8,240
-7,219
-47% -$13.8K ﹤0.01% 2909
2022
Q3
$37.1K Sell
15,459
-644
-4% -$1.55K ﹤0.01% 3321
2022
Q2
$30K Sell
16,103
-90,461
-85% -$168K ﹤0.01% 3015
2022
Q1
$223K Buy
106,564
+3,220
+3% +$6.73K ﹤0.01% 2526
2021
Q4
$407K Buy
103,344
+88,103
+578% +$347K ﹤0.01% 2478
2021
Q3
$73.3K Buy
15,241
+12,484
+453% +$60K ﹤0.01% 2805
2021
Q2
$12.7K Sell
2,757
-4,041
-59% -$18.5K ﹤0.01% 3066
2021
Q1
$39.9K Sell
6,798
-1,057
-13% -$6.21K ﹤0.01% 3091
2020
Q4
$26.9K Sell
7,855
-1,672
-18% -$5.72K ﹤0.01% 3128
2020
Q3
$13.7K Buy
9,527
+6,653
+231% +$9.58K ﹤0.01% 3290
2020
Q2
$5.73K Sell
2,874
-10,846
-79% -$21.6K ﹤0.01% 3321
2020
Q1
$26.8K Buy
13,720
+7,992
+140% +$15.6K ﹤0.01% 3210
2019
Q4
$23.8K Sell
5,728
-1,986
-26% -$8.24K ﹤0.01% 3278
2019
Q3
$23.2K Buy
7,714
+2,021
+35% +$6.08K ﹤0.01% 3243
2019
Q2
$35.8K Sell
5,693
-4,241
-43% -$26.7K ﹤0.01% 3007
2019
Q1
$55.2K Buy
9,934
+8,979
+940% +$49.9K ﹤0.01% 2861
2018
Q4
$6.34K Sell
955
-1,661
-63% -$11K ﹤0.01% 2823
2018
Q3
$27.9K Buy
2,616
+184
+8% +$1.96K ﹤0.01% 2617
2018
Q2
$29.2K Sell
2,432
-6,948
-74% -$83.4K ﹤0.01% 2696
2018
Q1
$80.4K Buy
9,380
+184
+2% +$1.58K ﹤0.01% 2730
2017
Q4
$90.9K Buy
9,196
+4,061
+79% +$40.1K ﹤0.01% 2698
2017
Q3
$63.1K Sell
5,135
-311
-6% -$3.82K ﹤0.01% 2593
2017
Q2
$89.6K Buy
5,446
+4,537
+499% +$74.6K ﹤0.01% 2442
2017
Q1
$13K Sell
909
-464
-34% -$6.65K ﹤0.01% 2612
2016
Q4
$19K Sell
1,373
-2,148
-61% -$29.7K ﹤0.01% 2693
2016
Q3
$63.6K Buy
3,521
+1,873
+114% +$33.8K ﹤0.01% 2324
2016
Q2
$23.6K Buy
+1,648
New +$23.6K ﹤0.01% 2523
2016
Q1
Sell
-9,016
Closed -$120K 2904
2015
Q4
$120K Buy
9,016
+170
+2% +$2.26K ﹤0.01% 2209
2015
Q3
$95K Buy
+8,846
New +$95K ﹤0.01% 2427
2015
Q2
Sell
-824
Closed -$5.43K 3588
2015
Q1
$5.43K Buy
+824
New +$5.43K ﹤0.01% 3108
2014
Q4
Sell
-1,921
Closed -$19K 2422
2014
Q3
$19K Buy
+1,921
New +$19K ﹤0.01% 2739
2014
Q2
Sell
-150
Closed -$1.61K 3395
2014
Q1
$1.61K Sell
150
-346
-70% -$3.72K ﹤0.01% 2289
2013
Q4
$6.26K Sell
496
-8,555
-95% -$108K ﹤0.01% 2469
2013
Q3
$151K Sell
9,051
-1,902
-17% -$31.7K ﹤0.01% 2012
2013
Q2
$166K Buy
+10,953
New +$166K ﹤0.01% 2077